Skip to main content
logo
Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.900
-0.020 (-1.04%)
At close: Jul 2, 2026, 4:00 PM EDT
1.889
-0.011 (-0.60%)
After-hours: Jul 2, 2026, 7:11 PM EDT

Serina Therapeutics Revenue

Serina Therapeutics had revenue of $130.00K in the twelve months ending March 31, 2026. In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.

Revenue (ttm)
$130.00K
Revenue Growth
+132.14%
P/S Ratio
227.27
Revenue / Employee
$8,125
Employees
16
Market Cap
28.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025130.00K74.00K132.14%
Dec 31, 202456.00K-3.10M-98.22%
Dec 31, 20233.15M3.12M9,173.53%
Dec 31, 202234.00K-110.00K-76.39%
Dec 31, 2021144.00K-217.00K-60.11%
Dec 31, 2020361.00K-1.37M-79.11%
Dec 31, 20191.73M332.00K23.78%
Dec 31, 20181.40M-8.00K-0.57%
Dec 31, 20171.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Barinthus Biotherapeutics14.97M
Kyntra Bio7.44M
Plus Therapeutics5.18M
Daré Bioscience1.16M
IGC Pharma1.11M
Lisata Therapeutics170.00K
Actinium Pharmaceuticals90.00K
Revenue Rankings

SER News

More News